Mitoguazone | Interleukin Related interleukin-related.com

Product Name :
Mitoguazone

Search keywords :
Mitoguazone

drugId :
null

Target Vo:
S-adenosylmethionine decarboxylase 1

Target Vo Short Name :
AMD1

Moa_Name:
S-adenosylmethionine decarboxylase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
National Cancer Institute

Active Company_Name :
Pontificia Universidad Javeriana

Active Indication_Name:
Leukemia

In Active Indication_Name:
HIV Infections

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Farletuzumab ecteribulin supplier
Fianlimab Technical Information
ACE Antibody: ACE Antibody is an unconjugated, approximately 147 kDa, rabbit-derived, anti-ACE polyclonal antibody. ACE Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, sheep background without labeling.

Author: Interleukin Related

Related Posts